안국약품
001540KOSDAQ· 의료용 물질 및 의약품 제조업10,290원+90 (+0.88%)전일 종가 2026-09-18
52주 위치
7,28013,65047%신고가 대비 -24.62%
- 시가총액
- 1,342억
- PER
- 5.40
- PBR
- 0.75
- EPS(TTM)
- 1,905원
- BPS
- 13,702원
- 배당수익률
- 6.15%
- 자사주비율
- 12.86%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | 2.57% | 4.46% | 0.84% | 10.60% | 4.52% |
| ROA | 1.70% | 3.10% | 0.43% | 6.04% | 2.39% |
| 영업이익률 | -0.66% | 4.71% | 2.17% | 2.47% | 3.20% |
| 순이익률 | 2.29% | 3.35% | 0.43% | 6.03% | 2.39% |
| 매출총이익률 | 61.77% | 61.48% | 60.16% | 61.93% | 65.27% |
| 부채비율 | 43.50% | 44.77% | 57.32% | 83.64% | 86.99% |
| 유동비율 | 222.72% | 198.39% | 173.07% | 174.89% | 164.93% |
| 매출 성장률(YoY) | — | 25.59% | 13.77% | 16.02% | 13.19% |
| 영업이익 성장률(YoY) | — | — | -47.69% | 32.40% | 46.57% |
| 순이익 성장률(YoY) | — | 83.76% | -85.49% | 1537.13% | -55.21% |
| FCF | -25.63억 | -11.43억 | -68.02억 | -710억 | 372억 |
| FCF 마진 | -1.57% | -0.56% | -2.91% | -26.18% | 12.13% |
| CAPEX/매출 | 2.47% | 1.43% | 2.34% | 27.99% | 2.76% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.92% | 2.05% | 0.84% | 0.80% | 2.52% | 0.35% | 1.77% | 0.46% | 0.43% | -1.79% | 5.00% | 5.99% | -0.26% | -0.11% | 2.24% | 1.88% | 2.01% | -1.56% | 7.44% | 4.94% |
| ROA | 0.63% | 1.37% | 0.58% | 0.57% | 1.83% | 0.21% | 1.23% | 0.32% | 0.28% | -1.31% | 2.92% | 3.65% | -0.14% | -0.24% | 1.15% | 1.01% | 1.11% | -0.85% | 3.93% | 2.71% |
| 영업이익률 | 3.27% | -3.18% | 3.08% | 2.93% | 8.53% | 3.98% | 6.76% | 1.16% | -0.03% | 1.04% | 4.66% | 2.51% | 1.05% | 1.76% | 7.73% | 6.46% | 6.29% | -7.68% | 16.19% | 9.41% |
| 순이익률 | 3.30% | 6.41% | 2.64% | 2.51% | 7.41% | 0.83% | 4.89% | 1.18% | 1.14% | -4.71% | 11.69% | 14.42% | -0.55% | -0.93% | 4.63% | 4.00% | 4.32% | -3.41% | 12.53% | 9.34% |
| 매출총이익률 | 61.87% | 63.64% | 60.28% | 59.85% | 62.47% | 62.93% | 63.28% | 59.52% | 60.74% | 57.55% | 59.58% | 62.41% | 61.32% | 64.23% | 63.75% | 64.52% | 66.30% | 66.49% | 66.84% | 67.14% |
| 부채비율 | 38.14% | 43.50% | 44.62% | 43.05% | 43.24% | 44.77% | 44.21% | 46.25% | 47.60% | 57.32% | 94.28% | 82.87% | 83.13% | 83.64% | 88.20% | 84.06% | 81.37% | 86.99% | 90.95% | 84.17% |
| 유동비율 | 248.35% | 222.72% | 198.80% | 212.89% | 213.94% | 198.39% | 197.83% | 193.06% | 190.03% | 173.07% | 147.59% | 175.62% | 174.28% | 174.89% | 169.48% | 176.68% | 179.17% | 164.93% | 161.85% | 168.66% |
| 매출 성장률(YoY) | — | — | — | — | 32.13% | 20.50% | 17.01% | 22.46% | 3.69% | 13.20% | 19.11% | 14.01% | 21.96% | 10.09% | 15.23% | 14.36% | 15.08% | 8.37% | 30.59% | 19.56% |
| 영업이익 성장률(YoY) | — | — | — | — | 245.11% | — | 156.61% | -51.63% | -100.40% | -70.46% | -17.90% | 147.53% | — | 86.56% | 91.15% | 194.46% | 590.23% | -572.99% | 173.53% | 74.02% |
| 순이익 성장률(YoY) | — | — | — | — | 196.30% | -84.42% | 116.79% | -42.50% | -84.06% | -743.20% | 184.70% | 1295.45% | -159.06% | — | -54.41% | -68.30% | — | — | 253.71% | 179.23% |
| FCF | 12.94억 | 21.24억 | -27.38억 | -6.93억 | 44.2억 | -21.31억 | 21.76억 | 3.25억 | -99.96억 | 6.93억 | -761억 | 15.68억 | 43.88억 | -8.34억 | 36.67억 | 227억 | 118억 | -9.24억 | 80.93억 | 102억 |
| FCF 마진 | 3.20% | 4.51% | -5.81% | -1.44% | 8.28% | -3.76% | 3.94% | 0.55% | -18.06% | 1.08% | -115.75% | 2.33% | 6.50% | -1.18% | 4.84% | 29.58% | 15.13% | -1.21% | 8.18% | 11.08% |
| CAPEX/매출 | 2.98% | 1.79% | 1.85% | 0.33% | 1.42% | 2.01% | 2.90% | 1.26% | 2.82% | 2.45% | 98.80% | 8.20% | 7.07% | 0.93% | 1.30% | 2.13% | 3.46% | 4.11% | 1.69% | 3.01% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 06:19· 연결 · 산식은 항목 툴팁